GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Santen Pharmaceutical Co Ltd (OTCPK:SNPHY) » Definitions » 5-Year Yield-on-Cost %

Santen Pharmaceutical Co (Santen Pharmaceutical Co) 5-Year Yield-on-Cost %

: 2.95 (As of Today)
View and export this data going back to 2010. Start your Free Trial

Santen Pharmaceutical Co's yield on cost for the quarter that ended in Dec. 2023 was 2.95.


The historical rank and industry rank for Santen Pharmaceutical Co's 5-Year Yield-on-Cost % or its related term are showing as below:

SNPHY' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.35   Med: 2.12   Max: 4.25
Current: 2.95


During the past 13 years, Santen Pharmaceutical Co's highest Yield on Cost was 4.25. The lowest was 1.35. And the median was 2.12.


SNPHY's 5-Year Yield-on-Cost % is ranked better than
59.44% of 498 companies
in the Drug Manufacturers industry
Industry Median: 2.24 vs SNPHY: 2.95

Competitive Comparison

For the Drug Manufacturers - General subindustry, Santen Pharmaceutical Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Santen Pharmaceutical Co 5-Year Yield-on-Cost % Distribution

For the Drug Manufacturers industry and Healthcare sector, Santen Pharmaceutical Co's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Santen Pharmaceutical Co's 5-Year Yield-on-Cost % falls into.



Santen Pharmaceutical Co 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Santen Pharmaceutical Co is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Santen Pharmaceutical Co  (OTCPK:SNPHY) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Santen Pharmaceutical Co 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Santen Pharmaceutical Co's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Santen Pharmaceutical Co (Santen Pharmaceutical Co) Business Description

Traded in Other Exchanges
Address
Grand Front Osaka Tower A, 4-20 Ofuka-cho, Kita-ku, Osaka, JPN, 530-8552
Santen Pharmaceutical Co Ltd is a drug manufacturing company that focuses on ophthalmic products. The company reports two primary operating segments: prescription ophthalmic pharmaceuticals and other. The pharmaceuticals segment includes over-the-counter pharmaceuticals, while the other segment includes medical devices. The vast majority of Santen's revenue is derived from its prescription ophthalmic pharmaceuticals segment, which manufactures and distributes prescription and OTC pharmaceuticals. Most of Santen's sales are generated in Japan, followed by other Asian countries.

Santen Pharmaceutical Co (Santen Pharmaceutical Co) Headlines

From GuruFocus

Matthews Japan Fund Comments on Santen Pharmaceutical

By Sydnee Gatewood Sydnee Gatewood 04-23-2020

Matthews Japan Fund 1st-Quarter Commentary

By Sydnee Gatewood Sydnee Gatewood 04-23-2020